In 2023, the incidence of Hepatitis B in the UK stood at 500 cases per hundred persons. The forecast from 2024 to 2028 shows a consistent decline in incidence, with a dip from 400 cases in 2024-2025 to 300 cases by 2026 and steadying at that level through 2028. Year-on-year analysis suggests a significant decrease of approximately 25% from 2025 to 2026. The five-year Compound Annual Growth Rate (CAGR) projects an average annual decrease of 11.2%, reflecting a favorable trend in controlling the disease.
Future trends to watch include:
- Ongoing public health initiatives targeting vaccination and prevention.
- Potential changes in healthcare policies affecting disease management.
- Advancements in medical research that could impact Hepatitis B treatments and prevention strategies.
